All News
Routine Urodynamics Fails to Improve Overactive Bladder Beyond Clinical Evaluation
(MedPage Today) -- Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomi
Read More5 High-Level CDC Officials Are Leaving in the Latest Turmoil for the Agency
(MedPage Today) -- The CDC was rocked by five high-level departures on Tuesday in the latest turmoil for the nation's top public health agency.
Read MoreFDA OKs New Option for Uncomplicated UTIs in Women, Girls
(MedPage Today) -- The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 years and up, GSK announced on Tuesday.
Read MoreWhat Does the Science Say About Cell Phones and Cancer?
(MedPage Today) -- In an interview with "Fox & Friends" last week, HHS Secretary Robert F. Kennedy Jr.
Read MoreNCD for Tricuspid Valve Procedures; Flavanols & BP; Infective Endocarditis Up
(MedPage Today) -- Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA-approved indicati
Read MoreDementia-Shingles Vax Study; ALS Cluster Spotted; Why Dementia Tsunami May Subside
(MedPage Today) -- GSK is partnering with the U.K. Dementia Research Institute and Health Data Research U.K.
Read MoreTrump nominates Republican once accused of mishandling taxpayer funds as HHS watchdog
President Trump has nominated a Republican attorney who was once accused of mishandling taxpayer funds to lead HHS' Office of Inspector General.
Read MoreSTAT+: NIH cuts halt 24-year program to prevent HIV/AIDS in adolescents and young adults
NIH terminated grants for a program studying how to diagnose, treat, and prevent HIV and AIDS in adolescents
Read More5 high-level CDC officials are leaving in the latest turmoil for the public health agency
The CDC was rocked by five high-level departures on Tuesday in the latest turmoil for the nation's top public health agency.
Read MoreCurtains for Tirzepatide Compounding; Redefining Obesity; Menopause and Salary
(MedPage Today) -- Last week marked the FDA's deadline for compounders to stop making the obesity drug tirzepatide (Zepbound), leaving some patients unsure where to turn next.
Read More